baber/WOPTO huggingface dataset:
Patent AU-2019230534-A1 (AU)
Title: Methods and kits for producing a fibrin matrix
Inventor: VOGT LORENZ
IPC: A61L27/22
Filed: 2019-02-25
Abstract: Methods for producing a fibrin matrix comprising a fusion peptide are described herein. In some embodiments, the method includes providing three different components, including a first component containing fibrinogen or a fibrinogen precursor and optionally, transglutaminase or a transglutaminase precursor, a second component containing thrombin or a thrombin precursor, and a third component containing a fusion peptide. In these embodiments, neither the first component nor the second component includes the fusion peptide. In some embodiments, the first or second components are premixed with the third component. The first, second and third components are mixed to form a fibrin matrix comprising a covalently linked fusion peptide. The mixing is carried out in a time frame of not more than 5 days. A kit for producing the fibrin matrix comprising a covalently linked fusion peptide is also described herein.
Patent AU-2019235415-A1 (AU)
Title: Timer for monitoring lapse of time relative to a total amount of allowed time
Inventor: OVERHOFF RENATUS WILHELMUS SERAPHINUS
IPC: G04G9/02
Filed: 2019-03-14
Abstract: The present disclosure relates to a timer to monitor lapse of time relative to a total amount of allowed time, comprising: - a body and a foot on or of the body, wherein the apparatus can rest on at least the foot; - a sensor; - a processor connected to the sensor and configured to monitor lapse of time; and - an output device connected to the processor, wherein the processor is configured to control the output device to generate a signal at least indicating monitored, lapsed time relative to the total amount of allowed time; characterized in that - the sensor is configured to indicate whether the timer rests on the foot; and - the processor is configured to monitor lapse of time, during which it is indicated by the sensor that the timer rests on the foot, and stop or pause to monitor lapse of time, when the timer rests not or not only on the foot; and - the processor is configured to control the output device to generate a signal at least indicating monitored, lapsed time, during which the timer rests on the foot, relative to the total amount of allowed time; wherein the total amount of allowed time is at least a portion of a calendar unit of time, such as an hour, morning, afternoon, evening, entire day or night, week, month or year, and the processor is configured to reset the total amount of allowed time only upon lapse of the calendar unit of time.
Patent AU-2019240695-A1 (AU)
Title: Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
Inventor: BAGRODIA SHUBHA
IPC: A61K47/34
Filed: 2019-10-04
Abstract: Abstract The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid and a therapeutic agent (1-(4-{[4-(dimethylamino)piperidin-1 yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea), or pharmaceutically acceptable salts thereof, and a polymer. Other aspects include methods of making and using such nanoparticles.
Patent AU-2019249271-A1 (AU)
Title: Location and flow rate meter
Inventor: KRYWYJ DANIEL MILNE
IPC: G01F1/66
Filed: 2019-04-05
Abstract: Apparatuses and methods for detecting and determining flow within a water release assembly are provided. The water release assembly may include a fluid flow passage with an inlet and an outlet, a flow meter for detecting fluid flow through the fluid flow passage, an attachment structure for attaching the fluid flow passage to an external fluid flow conduit, and a fluid flow processing module configured to acquire and store location data that is related to a geographic location of the fluid flow processing module, store fluid flow data that is related to fluid flow through the fluid flow passage and is based, at least in part, on the fluid flow detected by the flow meter, and wirelessly transmit the location data and the fluid flow data to an external computer.
Patent AU-2019315702-A1 (AU)
Title: Thickener combination for agrochemical (crop protection) formulations with high salt content
Inventor: DECKWER ROLAND
IPC: A01P13/00
Filed: 2019-07-31
Abstract: The invention relates to the technical field of thickener combinations for crop protection formulations with high salt content, in particular herbicidal formulations, and formulations containing said adjuvant combinations, as well as methods for producing said formulations. In a preferred embodiment, the instant invention relates to aqueous formulations of water-soluble active ingredients, in particular aqueous formulations of saltlike active ingredients, and especially to formulations containing glufosinate and or glyfosate, in combination with at least one further water insoluble active ingredient, which is suspended in the formulation, wherein the formulations contain a high salt content.
Patent AU-2019317840-A1 (AU)
Title: Technique simulator
Inventor: TAKAHASHI MAKOTO
IPC: G09B9/00
Filed: 2019-05-31
Abstract: The present invention provides a technique simulator with which it is possible to experience that a pressure difference is generated by blocking a blood vessel using a balloon and it is possible to selectively administer a therapeutic agent to a specific region. A technique simulator (10A) comprises a flow path (12) including a liquid (L) that imitates blood, a liquid flow generation member for adding a flow to the liquid (L), and a catheter insertion port (14). The flow path (12) has a first branched flow path (24) and a second branched flow path (26) downstream of a branching unit (22). The technique simulator (10A) furthermore includes a pressure difference generation member for generating a pressure difference between the downstream side of the first branched flow path (24) and the downstream side of the second branched flow path (26). The liquid flow generation member generates pressure higher than the pressures applied to the downstream side of the first branched flow path (24) and the downstream side of the second branched flow path (26).
Patent AU-2019334563-A1 (AU)
Title: Method for enriching a biomass with proteins
Inventor: CAGNAC OLIVIER
IPC: A23L33/195
Filed: 2019-09-05
Abstract: The present invention relates to a method for protein enrichment of a biomass of red unicellular algae such as
Patent AU-2019409541-A1 (AU)
Title: Skin-mountable medical device
Inventor: ARNOLD MARC
IPC: A61M5/14
Filed: 2019-12-17
Abstract: The invention concerns a skin-mountable medical device (10) comprising a mounting plate (12) having a bottom side (26) attachable to the skin of a user, a medical module (14), in particular an analyte sensing device or a drug administration pump, and a snap connector (16) adapted to releasably attach the medical module (14) on the upper side (34) of the mounting plate (12), wherein the snap connector (16) has a release flap (16) that can be actuated by the user to detach the medical module (14), and the release flap (16) projects outwardly from the mounting plate (12) and at its bottom side (26) maintains a clearance (24) to avoid an interfering skin contact in use.
Patent WO-2021022341-A1 (WO)
Title: Procédés de production de fumier traité
Inventor: KINLEY ROBERT
IPC: C05F17/80
Filed: 2020-08-10
Abstract: La présente invention concerne un procédé et des additifs pour la production de fumier animal traité.
Patent AU-2020201708-A1 (AU)
Title: Techniques for encoding, decoding and representing high dynamic range images
Inventor: NINAN AJIT
IPC: H04N19/36
Filed: 2020-03-06
Abstract: Techniques for high dynamic range image processing are presented. Base layer data, first checksum parameter, and residual ratio data for a high dynamic range (HDR) image are each received. A second checksum parameter is computed for the base layer data based upon the first 5 SOF after the last APPI1 marker segment and includes all following bytes up to and including the EOI marker. The first and second checksum parameters are compared to determine if base layer has been altered.
Patent AU-2020205621-A1 (AU)
Title: Compositions of polynucleic acid vectors and uses thereof
Inventor: NIELSEN ALEC A K
IPC: C12N15/09
Filed: 2020-01-07
Abstract: Disclosed herein are compositions of destination and entry vectors. Also disclosed herein are the use of destination and entry vectors in methylation-obstructed assembly reactions, wherein the assembled sequences may be used as entry vectors in subsequent assembly reactions.
Patent AU-2020239638-A1 (AU)
Title: Prosthetic capsular devices, systems, and methods
Inventor: WORTZ GARY N
IPC: A61L27/14
Filed: 2020-09-22
Abstract: A prosthetic capsular device configured to be inserted in an eye after removal of a lens, in 
some embodiments, can comprise a housing structure comprising capable of containing an 
intraocular device and an equiconvex refractive surface. The housing structure can comprise 
an anterior portion comprising an anterior opening, a posterior portion comprising a posterior 
opening, and a continuous lateral portion between the anterior portion and the posterior 
portion.
Patent AU-2020252087-A1 (AU)
Title: Mixed-cell gene therapy
Inventor: NOH MOON JONG
IPC: A61L27/38
Filed: 2020-03-30
Abstract: The subject invention is directed to a mixed cell composition to generate a therapeutic protein at a target site by providing a first population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene, wherein endogenously existing forms of the second population of mammalian cells are decreased at the target site, and wherein generation of the therapeutic protein by the first population of mammalian cells at the target site stimulates the second population cells to induce a therapeutic effect.
Patent AU-2020271791-A1 (AU)
Title: Solid pharmaceutical compositions for treating HCV
Inventor: LIU WEI
IPC: A61K9/16
Filed: 2020-04-01
Abstract: The present invention features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes (1) a first type of film-coated granules which comprise 50 mg of Compound 1, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion; and (2) a second type of film-coated granules which comprise 20 mg of Compound 2, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion.
Patent AU-2020289842-A1 (AU)
Title: Device and method for managing registration and arrangement of detonator
Inventor: HWANG KI WON
IPC: F42D1/045
Filed: 2020-12-04
Abstract: A device and a method for managing registration and arrangement of a detonator are 
proposed. The device includes: a detonator arrangement part configured to arrange, in 
response to a request for registration of a detonator input by an operator, the detonator on a 
detonator hole number according to a blasting pattern pre-designed on the basis of 
arrangement information input by the operator or arranging the detonator on the basis of an 
arrangement pattern of pre-arranged detonators; an arrangement result analysis part 
configured to analyze an arrangement result of the detonator that is arranged according to the 
arrangement pattern of the pre-arranged detonators; and an arrangement error notification 
part configured to provide notification to the operator when the analyzed arrangement result 
has an error.
Patent AU-2020316002-A1 (AU)
Title: Compositions and methods comprising protease-activated therapeutic agents
Inventor: HUBBELL JEFFREY
IPC: C07K14/54
Filed: 2020-07-24
Abstract: The disclosure relates to the engineering of collagen-binding modification of masked therapeutic agents comprising one or more tumor-associated protease cleavage sites. Upon exposure to tumor-associated proteases in the tumor microenvironment, the polypeptide is cleaved, which unmasks the therapeutic agent, reducing off-target side effects and toxicity associated with systemic administration. Accordingly, aspects of the disclosure relate to a polypeptide comprising a therapeutic agent linked to a masking agent through a linker, wherein the linker comprises one or more tumor-associated protease cleavage sites, and wherein the masking agent blocks the association of the therapeutic agent to its therapeutic target, and further wherein the polypeptide is operatively linked to a collagen binding domain or a tumor-targeting agent.
Patent AU-2020319662-A1 (AU)
Title: New pharmaceutical formulation
Inventor: WAGNER-HATTLER LEONIE FLURINA CLAUDE
IPC: A61K31/496
Filed: 2020-07-29
Abstract: Disclosed herein are pharmaceutical compositions and dosage forms including N-[5-(3,5- difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4- ylamino) benzamide that are useful in the treatment of subjects having cancer. The present disclosure also provides methods for preparing these pharmaceutical compositions and dosage forms, and methods of treating subjects having cancer utilizing the pharmaceutical compositions and dosage forms provided herein.
Patent AU-2020329283-A1 (AU)
Title: Point cloud occlusion mapping for autonomous vehicles
Inventor: BYBEE TAYLOR C
IPC: G01C21/32
Filed: 2020-08-13
Abstract: Some embodiments of the invention include a method for updating an occlusion probability map. An occlusion probability map,ap represents the probability that a given portion of the sensor field is occluded from one or more sensors. In some embodiments, a method may include receiving field of view data from a sensor system; producing a probabilistic model of the sensor field of view; and updating an occlusion probability map using the probabilistic model and field of view data.
Patent AU-2020370260-A1 (AU)
Title: Intramedullary fixation nail and method of use
Inventor: ORBAY JORGE
IPC: A61B17/92
Filed: 2020-10-22
Abstract: Disclosed is an intramedullary nail comprising a shaft having a length, a constant diameter, an exterior bone contacting surface, a leading (or distal) end and a trailing (or proximal) end, wherein the leading end is progressively tapered and comprises a well or cup, adapted to receive the tip of a standard K-wire, the trailing end comprises a driving fitting adapted for attachment to a driving tool for insertion of the nail into the prepared bone, the trailing end may optionally include an internal thread that can be used to secure the nail to a drill guide which can also function as an insertion handle, and the nail's shaft may also optionally be equipped with threaded and/or unthreaded cross-drilled holes for insertion of unicortical locking screws and bone screws, respectively, once the nail is placed as desired.
Patent AU-2020399072-A1 (AU)
Title: Compressor with a system for removing liquid from the compressor
Inventor: BIGI MANUELE
IPC: F04D29/42
Filed: 2020-12-10
Abstract: The centrifugal compressor comprises a casing and a rotor arranged in the casing and configured to rotate around a vertical rotation axis. The rotor comprises at least one impeller having an impeller suction side and an impeller delivery side. The compressor includes a gas inlet and a gas outlet, as well as a gas flow path extending from the gas inlet to the gas outlet. An inlet plenum extends from the gas inlet towards the impeller suction side. At least one suction tube having a lower suction end and an upper discharge end is arranged such that the lower suction end thereof is arranged at a bottom of the inlet plenum. The suction tube extends upwardly towards the impeller suction side.
Patent AU-2020409247-A1 (AU)
Title: Egg allergy preventing agent or the like, and food composition containing same
Inventor: AYABE Ayako
IPC: A61P37/08
Filed: 2020-12-18
Abstract: The present invention provides a highly effective and safe means capable of preventing or treating egg allergy in infants. According to the present invention, an oral immunotolerant or a food composition for preventing or treating egg allergy contains a degradation product of egg white heat-denatured by aspartic protease (for example, pepsin) or metalloprotease (for example, thermolysin).
Patent AU-2020464490-A1 (AU)
Title: Preparation method for and use of high-purity powder material and biphasic powder material
Inventor: ZHAO YUANYUN
IPC: B22F9/08
Filed: 2020-12-08
Abstract: A preparation method for and use of a high-purity powder material and a biphasic powder material. The high-purity powder material is prepared by means of atomization comminuting and a phase removal method. In the preparation method, firstly, intermediate alloy powder in which a second-phase matrix covers first-phase particles is prepared by using an atomization comminuting technique. During solidification of the intermediate alloy powder, impurity elements are concentrated to the second-phase matrix, so that the first-phase particles are purified. The second-phase matrix in the intermediate alloy powder is removed, so that a high-purity target powder material consisting of the original first-phase particles can be obtained. The preparation method has the characteristics of simple processes, easy operations and low costs, can prepare various high-purity powder materials comprising nanoscale, submicron-scale and micron-scale materials, and has good application prospects in the fields of catalytic materials, powder metallurgy, composite materials, wave-absorbing materials, sterilization materials, metal injection molding, 3D printing and additive manufacturing, coating, etc.
Patent WO-2022261694-A1 (WO)
Inventor: THOMSON DARREN
IPC: E21B10/00
Filed: 2021-06-16
Abstract: A component for a drill string, the component having a central axis and comprising: (a) a trailing end; (b) a leading end; and (c) at least one fluid flow enhancing element projecting from an outer surface of the component for enhancing fluid flow towards said trailing end, when the drill string is rotated around said axis in a direction of rotation.
Patent WO-2022020878-A1 (WO)
Title: Dispositif d'administration d'agent, système d'administration d'agent, et méthode d'administration d'un agent
Inventor: JOHNSON MICHAEL RALPH BURGESS
IPC: A61M15/08
Filed: 2021-07-13
Abstract: La présente divulgation concerne un dispositif d'administration d'agent (1) pour l'administration d'un agent thérapeutique ou d'un agent médicinal à un individu. Le dispositif d'administration d'agent (1) comprend : un cadre (2) ayant au moins un élément de cadre (4) configuré pour être reçu et retenu ou logé à l'intérieur d'une narine de l'individu; et un élément d'administration (8) disposé sur et/ou porté par l'au moins un élément de cadre (4) pour administrer l'agent, l'agent étant de préférence soit sous forme liquide ou semi-solide, soit contenu dans un milieu liquide ou gélifié. L'élément d'administration (8) est disposé sur et/ou porté par l'élément de cadre de sorte que, lorsque l'élément de cadre est logé dans une narine, l'élément d'administration (8) entre en contact ou vient en prise avec une surface interne (par exemple, un tissu) de la narine pour administrer l'agent à l'individu, par exemple, par voie percutanée. De cette manière, le dispositif d'administration d'agent (1) a un élément d'administration (8) prévu sur et/ou porté par un élément de cadre (4) reçu et retenu ou logé à l'intérieur d'une narine de l'individu pour y administrer l'agent  in situ . La divulgation concerne également un kit d'administration d'agent, un système d'administration d'agent et des méthodes associées.
Patent AU-2021200848-A1 (AU)
Title: Binding machine
Inventor: ITAGAKI OSAMU
IPC: B65B13/16
Filed: 2021-02-10
Abstract: A binding machine includes: a wire feeding unit configured to feed a wire; a curl 
forming unit configured to form a path along which the wire fed by the wire feeding unit is to 
5 be wound around a to-be-bound object; a butting part against which the to-be-bound object is 
to be butted; a cutting unit configured to cut the wire wound on the to-be-bound object; a 
binding unit configured to twist the wire wound on the to-be-bound object and cut by the 
cutting unit; and a tension applying part configured to apply tension to the wire to be cut at 
the cutting unit with a force higher than a force applied in a loosening direction of the wire 
0 wound on the to-be-bound object.
1/28 
FIG.1I 
5A A1<-->A2 10OA 1 A 
50 90 70 71 c2 928 
50 0-A 171 c1 71392 83 8A 0 4 
M76d 62d74 
0/ s 
Ru ~91A 
S 
61 _ 0 C) r 
51 6A F .2 12A 83a 
60 R 0 6262a ° 3 
30 .62b 
3A 11A 
W-- . .  
2A 
20
15A
Patent AU-2021201666-A1 (AU)
Title: Light Detection Devices with Protective Liner and Methods Related to Same
Inventor: CAI XIUYU
IPC: H01L27/146
Filed: 2021-03-16
Abstract: A device is disclosed, comprising: a reaction structure that forms a plurality of reaction recesses; 
and a device base positioned beneath the reaction structure, comprising: a plurality of light 
sensors; device circuitry electrically coupled to the light sensors to transmit data signals based on 
photons detected by the light sensors; a plurality of light guides with input regions that receive 
excitation light and light emissions from at least one corresponding reaction recess of the 
reaction recesses, each light guide extending into the device base toward at least one 
corresponding light sensor of the light sensors, and said light guides comprising at least one filter 
material that filters the excitation light and permits the light emissions to pass to the at least one 
corresponding light sensor; and a protection layer extending about each light guide, where the 
protection layer is chemically inert with respect to a reaction solution that passes over the 
reaction structure.
Patent AU-2021203717-A1 (AU)
Title: CNP prodrugs
Inventor: SPROGOE KENNETT
IPC: A61P27/02
Filed: 2021-06-07
Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions 
comprising such CNP prodrugs, and their uses in treatment methods. In a preferred embodiment, the CNP 
prodrugs are conjugates of CNP peptides that are conjugated to poly(ethylene glycol) through a reversible 
linker.
Patent AU-2021206896-A1 (AU)
Title: Electronic ankle shackle and corresponding processes
Inventor: SICK MICHAEL
IPC: A61B5/00
Filed: 2021-07-23
Abstract: The present invention pertains to an electronic ankle shackle, to a process for a control unit of an 
electronic ankle shackle, as well as to a process for detecting alcohol in sweat. The electronic 
ankle shackle (10) comprises an electrochemical sensor (11) and an electrically operated heating 
element (12) for heating skin (20) in an area around the electrochemical sensor.  
20 
12 16 10 
#- 7--,- 14 
DEVICE 
1513 11 
Fig. 1a
1/3 
20 
12 16 10 
-- - --------------
CONTROL ' 
DEVICE 
- -- ------------------------
1513 11 
Fig.I1a 
Fig.l1b
Patent AU-2021223091-A1 (AU)
Title: System and method for integrated multimodal travel bookings
Inventor: CARSTENSEN RUSSELL
IPC: G06Q50/14
Filed: 2021-02-17
Abstract: A system for integrated multimodal travel bookings, the system comprising an application programming interface (API) aggregation gateway configured to provide multiple API connections to multiple travel inventory systems to access, retrieve and aggregate multiformat travel inventory data for a multimodal travel trip by a traveller and a workflow engine configured to execute multiple workflows to merge the aggregated multiformat travel inventory data into multiple travel bookings and send the multiple travel bookings to the multiple travel inventory systems and receive multiple travel confirmations from the multiple travel inventory providers and merge the multiple travel confirmations into an integrated multimodal travel itinerary for the traveller.